drugset / Trial / NCT01662921

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

NCT01662921

RandomizedParallel-groupOpen-labelTreatment

Summary

We hypothesize that insulin glulisine is non-inferior to currently proven rapid-acting insulin lispro when used in a basal/bolus regimen to treat hyperglycemia in patients with gestational diabetes mellitus.

Timeline

Start
2013-04
Primary completion
2015-01-31
Completion
2015-08-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Lispro Protein / enzyme biologic
Comparator Insulin glulisine Protein / enzyme biologic
Comparator NPH Protein / enzyme biologic

Indications